Company / CapEx per Share
Exelixis CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.03
FY2025
5-year range
$0.03 / $0.12
FY2021-FY2025
Trend
-68.1%
vs FY2024
Sector context
#85 of 192
Health Care
What the data says
At $0.03, Exelixis's capex per share ranks #85 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2018 to $0.12 in FY2023.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -21.4%.
Declined from $0.12 to $0.03 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -32.0%
- 5-Year CAGR
- -21.4%
- 10-Year CAGR
- -
Sector benchmark
#85 of 192 in Health CareTop 44% of 192This company $0.03 Sector average $2.46
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 68.1% year-over-year.
- Ranks #85 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2023.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | -68.1% |
| FY2024 | $0.09 | -24.8% |
| FY2023 | $0.12 | +31.3% |
| FY2022 | $0.10 | +131.1% |
| FY2021 | $0.04 | -58.6% |
| FY2020 | $0.10 | +132.6% |
| FY2019 | $0.04 | +644.4% |
| FY2018 | $0.01 | -92.1% |
| FY2017 | $0.07 | +876.2% |
| FY2016 | $0.01 | +227.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026